Is this you? Create Your Porfile
Avatar

David F. Duncan

Dendreon

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where David F. Duncan is active.

Explore More

Publication

Featured researches published by David F. Duncan.

The Prostate | 2004

CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.

Anna V. Galkin; Lynne Mullen; William D. Fox; Jason Brown; David F. Duncan; Ofir Moreno; Edwin L. Madison; David B. Agus

Archive | 2004

Compositions and methods for the treatment of disease associated with TRP-P8 expression

Sateesh Natarajan; Ofir Moreno; Thomas Graddis; David F. Duncan; Reiner Laus; Feng Chen

Archive | 2000

Plasminogen activator inhibitor antagonists

Edwin L. Madison; Terence K. Brunck; Joseph Edward Semple; Marguerita Lim-Wilby; Kent E. Pryor; D. Lewis Ii Ronald; David F. Duncan; C. Maxwell Lawrence

Archive | 2000

Plasminogen activator inhibitor antagonists related applications

Edwin L. Madison; Terence K. Brunck; Joseph Edward Semple; Marguerita Lim-Wilby; Kent E. Pryor; Ronald D. Ii Lewis; David F. Duncan; C. Maxwell Lawrence

Archive | 2007

Small-molecule modulators of trp-p8 activity

Ofir Moreno; Sateesh Natarajan; David F. Duncan

Archive | 2003

Matriptase inhibitors and methods of use

David F. Duncan; L. Josue Alfaro-Lopez; Mallareddy Komandla; Odile E. Levy; Ofir Moreno; Joseph Edward Semple; Amir P. Tamiz

The Journal of Urology | 2009

PRECLINICAL EVALUATION OF THE TRPM8 ION CHANNEL AGONIST D-3263 FOR BENIGN PROSTATIC HYPERPLASIA

David F. Duncan; Frances P. Stewart; Mark W. Frohlich; David L. Urdal

Cancer Research | 2005

Sensitive assay of tumor S-adenosyl-methionine and S-adenosyl-homocysteine

Ofir Moreno; Feng Chen; David F. Duncan; Tom Graddis; Reiner Laus; Katie McDole; Stan Morkowski; Sateesh Natarajan; Celso Wang

The Journal of Urology | 2008

PRECLINICAL VALIDATION OF THE Trp-p8 ION CHANNEL AS A TARGET FOR BENIGN PROSTATIC HYPERPLASIA

David F. Duncan; Ofir Moreno; Mark W. Frohlich; David L. Urdal

Archive | 2007

Substituted cyclohexyl carboxamide modulators of trp-p8 activity

Ofir Moreno; Sateesh Natarajan; David F. Duncan

Explore More

Collaboration

Dive into the David F. Duncan's collaboration.

Top Co-Authors
Avatar

Ofir Moreno

Dendreon

View shared research outputs
Top Co-Authors
Avatar

Sateesh Natarajan

Dendreon

View shared research outputs
Top Co-Authors
Avatar

Joseph Edward Semple

Dendreon

View shared research outputs
Top Co-Authors
Avatar

Feng Chen

Dendreon

View shared research outputs
Top Co-Authors
Avatar

Reiner Laus

Dendreon

View shared research outputs
Top Co-Authors
Avatar

Marguerita Lim-Wilby

Dendreon

View shared research outputs
Top Co-Authors
Avatar

Thomas Graddis

Dendreon

View shared research outputs
Top Co-Authors
Avatar

David L. Urdal

Dendreon

View shared research outputs
Top Co-Authors
Avatar

Mark W. Frohlich

Dendreon

View shared research outputs
Top Co-Authors
Avatar

Amir P. Tamiz

Dendreon

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge